wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q33864723-BC42D87F-F6D0-41A9-804E-E74332F1236F
Q33864723-BC42D87F-F6D0-41A9-804E-E74332F1236F
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33864723-BC42D87F-F6D0-41A9-804E-E74332F1236F
Bone-targeting agents in prostate cancer.
P2860
Q33864723-BC42D87F-F6D0-41A9-804E-E74332F1236F
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33864723-BC42D87F-F6D0-41A9-804E-E74332F1236F
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
b9a275b996db7d861d5a3053ec6f44e41ada9e1b
P2860
Phase II randomized, double-blind, placebo-controlled study of tasquinimod in men with minimally symptomatic metastatic castrate-resistant prostate cancer.